The influence of inflammation on anemia in CKD patients

A Gluba-Brzózka, B Franczyk, R Olszewski… - International journal of …, 2020 - mdpi.com
Anemia is frequently observed in the course of chronic kidney disease (CKD) and it is
associated with diminishing the quality of a patient's life. It also enhances morbidity and …

Risk factors for anemia in patients with chronic renal failure: a systematic review and meta-analysis

WS Shiferaw, TY Akalu, YA Aynalem - Ethiopian journal of health sciences, 2020 - ajol.info
BACKGROUND፡ Anemia in patients with chronic kidney disease presents significant
impacts on patients, the health-care system and financial resources. There is a significant …

Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: a 20-year cohort

ES Ferreira, TR Moreira, RG da Silva, GD da Costa… - BMC nephrology, 2020 - Springer
Background optimal management of end-stage renal disease (ESRD) in hemodialysis (HD)
patients should be more studied because it is a serious risk factor for mortality, being …

Predicting adverse events beyond stroke and bleeding with the ABC-stroke and ABC-bleeding scores in patients with atrial fibrillation: the Murcia AF project

A Camelo-Castillo, JM Rivera-Caravaca… - Thrombosis and …, 2020 - thieme-connect.com
Background The ABC (age, biomarkers, and clinical history)-stroke and ABC-bleeding are
biomarker-based scores proposed to predict stroke and bleeding, but non-specificity of …

Prevalence and associated risk factors for chronic kidney disease in the elderly physically disabled population in Shanghai, China: a cross-sectional study

H Wu, Y Li, L Ren, J Li, Y Wang, C Jiang, J Wu - BMC Public Health, 2023 - Springer
Background The global prevalence of chronic kidney disease (CKD) in the general
population is relatively clear. Our previous study showed that elderly individuals who are …

Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapies

CE Harlow, J Gandawijaya, RA Bamford… - The American Journal of …, 2022 - cell.com
Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are currently under clinical
development for treating anemia in chronic kidney disease (CKD), but it is important to …

Efficacy and safety of daprodustat for anemia therapy in chronic kidney disease patients: a systematic review and meta-analysis

Q Zheng, Y Wang, H Yang, L Sun, X Fu… - Frontiers in …, 2021 - frontiersin.org
Objective: Daprodustat is a novel oral agent in treating anemia of chronic kidney disease
(CKD), and several clinical trials have been conducted to compare daprodustat with …

Anemia and its predictors among chronic kidney disease patients in Sub-Saharan African countries: A systematic review and meta-analysis

MM Taderegew, A Wondie, TF Terefe, TT Tarekegn… - PLoS …, 2023 - journals.plos.org
Introduction Anemia is a serious complication of chronic kidney disease (CKD) with a
significant adverse outcome on the burden and progression of the disease. Hence, the study …

Prevalence of anemia and its associated factors among chronic kidney disease patients attending selected public hospitals of Addis Ababa, Ethiopia: Institutional …

B Alemu, T Techane, NG Dinegde… - International journal of …, 2021 - Taylor & Francis
Background Anemia is a global public health problem with high mortality and morbidity. It is
becoming more prevalent in Ethiopia. Therefore, this study aimed to estimate the prevalence …

Effects of blood urea nitrogen independent of the estimated glomerular filtration rate on the development of anemia in non-dialysis chronic kidney disease: The results …

HJ Kim, TE Kim, M Han, Y Yi, JC Jeong, HJ Chin… - PloS one, 2021 - journals.plos.org
Background Anemia is a common complication of chronic kidney disease (CKD). Blood urea
nitrogen (BUN) in CKD represents nitrogenous uremic toxin accumulation which could be …